General Keynote: Vaccine Strategies for the Therapy of Ovarian Cancer

This publication has 71 references indexed in Scilit:

• Immunogenicity of Whole-Cell Tumor Preparations Infected with the ALVAC Viral Vector
  Human Gene Therapy, 2000
• Effectiveness of cancer vaccine therapy using cells transduced with the interleukin-12 gene combined with systemic interleukin-18 administration
  Cancer Gene Therapy, 2000
• MUC1 and cancer
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1999
• Construction and Characterization of a Recombinant Vaccinia Virus Expressing Murine Intercellular Adhesion Molecule-1: Induction and Potentiation of Antitumor Responses
  Human Gene Therapy, 1997
• Therapeutic Antitumor Response After Immunization with an Admixture of Recombinant Vaccinia Viruses Expressing a Modified MUC1 Gene and the Murine T-Cell Costimulatory Molecule B7
  Journal of Immunotherapy, 1997
• Enhancement of Antitumor Immunity by CTLA-4 Blockade
  Science, 1996
• Co‐expression of B7‐1 and ICAM‐1 on tumors is required for rejection and the establishment of a memory response
  European Journal of Immunology, 1995
• T Cell Activation Pathways: B7, LFA-3, and ICAM-1 Shape Unique T Cell Profiles
  Critical Reviews in Immunology, 1995
• Human Naive and Memory T‐Helper Cells Display Distinct Adhesion Properties to ICAM‐1, LFA‐3 and B7 Molecules
  Scandinavian Journal of Immunology, 1993
• Pretreatment serum levels of CA-125, carcinoembryonic antigen, tissue polypeptide antigen, and placental alkaline phosphatase, in patients with ovarian carcinoma, borderline tumors, or benign adnexal masses: Relevance for differential diagnosis
  Gynecologic Oncology, 1990